CEO
Histone Therapeutics
Dr. Gregory Block is CEO, Co-Founder, & Board Chair at Histone Therapeutics.
Dr. Block holds a doctorate in Molecular Biology from Tulane University in New Orleans and a Masters of Biochemistry from the University of Toronto, where he studied the mechanisms of stem cell tissue regeneration and chromatin organization, under Dr. Darwin Prockop and Dr. David Bazett-Jones respectively. He completed his postdoctoral fellowship at the University of Washington where he discovered mechanistic insights and established the first cellular assays for measuring the underlying genetic defect for Facioscapulohumeral Muscular Dystrophy (FSHD). Dr. Block has since served on the board of directors and scientific advisory board of Friends of FSH Research, an organization devoted to finding a cure for FSHD.
Dr. Block is also an advisor to Creative Destruction Labs, a Canadian organization devoted to helping young companies scale massively.
He can be reached at greg@fshfriends.org.
Connect with us on social media